Biotron Ltd has released a press release.
Prospectus
Filed with ASX ·
On 6ix: 6ix.com/news/prospectus-104
6ix hasn’t read this filing yet.
Story so far
Earlier from Biotron
- Renounceable Rights Issue
- Updated Appendix 4C
- Agreement with C14 Consulting Group
- $1.8M R&D Rebate Received
- BIT225-012 phase 2 covid-19 clinical trial
Later from Biotron
- Response to ASX Aware Query
- Supplementary Prospectus
- Response to ASX Query Letter
- Replacement Prospectus
- Rights Issue Closed
Follow Biotron into a list and get an email when it puts out news.
Follow Biotron